ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,594.82
0.09%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Wave Life Sciences Ltd (WVE)

  7. Wave Life Sciences Ltd (WVE) Noticias

WVE

Wave Life Sciences (WVE)

Wave Life Sciences Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:WVE
FechaHoraFuenteTítuloSímboloCompañía
10/05/202406:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WVEWave Life Sciences Ltd
09/05/202406:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
09/05/202406:30GlobeNewswire Inc.Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:WVEWave Life Sciences Ltd
09/05/202406:00GlobeNewswire Inc.Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific OfficerNASDAQ:WVEWave Life Sciences Ltd
07/05/202407:30GlobeNewswire Inc.Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:WVEWave Life Sciences Ltd
02/05/202407:30GlobeNewswire Inc.Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024NASDAQ:WVEWave Life Sciences Ltd
30/04/202407:30GlobeNewswire Inc.Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)NASDAQ:WVEWave Life Sciences Ltd
23/04/202407:30GlobeNewswire Inc.Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA EditingNASDAQ:WVEWave Life Sciences Ltd
27/03/202407:30GlobeNewswire Inc.Wave Life Sciences to Present at Upcoming Investor ConferencesNASDAQ:WVEWave Life Sciences Ltd
06/03/202406:55Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:WVEWave Life Sciences Ltd
06/03/202406:30GlobeNewswire Inc.Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:WVEWave Life Sciences Ltd
28/02/202407:30GlobeNewswire Inc.Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024NASDAQ:WVEWave Life Sciences Ltd
27/02/202407:30GlobeNewswire Inc.Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular DystrophyNASDAQ:WVEWave Life Sciences Ltd
12/02/202415:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:WVEWave Life Sciences Ltd
07/02/202418:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
08/01/202407:00GlobeNewswire Inc.Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 MilestonesNASDAQ:WVEWave Life Sciences Ltd
03/01/202407:30GlobeNewswire Inc.Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:WVEWave Life Sciences Ltd
15/12/202307:30GlobeNewswire Inc.Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular DystrophyNASDAQ:WVEWave Life Sciences Ltd
08/12/202305:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:WVEWave Life Sciences Ltd
07/12/202306:00GlobeNewswire Inc.Wave Life Sciences Prices $100 Million Public Offering of Ordinary SharesNASDAQ:WVEWave Life Sciences Ltd
06/12/202315:10GlobeNewswire Inc.Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded WarrantsNASDAQ:WVEWave Life Sciences Ltd
06/12/202315:08GlobeNewswire Inc.Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin DeficiencyNASDAQ:WVEWave Life Sciences Ltd
22/11/202307:30GlobeNewswire Inc.Wave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI HealthCONx ConferenceNASDAQ:WVEWave Life Sciences Ltd
09/11/202307:52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:WVEWave Life Sciences Ltd
09/11/202306:30GlobeNewswire Inc.Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:WVEWave Life Sciences Ltd
03/11/202315:05GlobeNewswire Inc.Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023NASDAQ:WVEWave Life Sciences Ltd
28/09/202315:15GlobeNewswire Inc.Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D DayNASDAQ:WVEWave Life Sciences Ltd
25/09/202307:30GlobeNewswire Inc.Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines ConferenceNASDAQ:WVEWave Life Sciences Ltd
06/09/202307:30GlobeNewswire Inc.Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:WVEWave Life Sciences Ltd
05/09/202306:30GlobeNewswire Inc.Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-006, the First-ever RNA Editing Clinical Candidate, and Plans for Upcoming Virtual “R&D Day”NASDAQ:WVEWave Life Sciences Ltd
 Showing the most relevant articles for your search:NASDAQ:WVE

Su Consulta Reciente

LBNK
LXRNUSDT
Luxurion
COIN
ORNETH
Orion Protocol
LSE
CZ76
Bank Mont.34
LSE
71CN
Hsbc Bk.37
BTRX
CRMCUSDT
CHREMACOIN
USOTC
GSDI
Global Systems Dynamics (PK)
LSE
ASIU
Am China Leader
TSX
ZWEN
BMO Covered Call Energy ...
NASDAQ
ARBEW
Arbe Robotics
NASDAQ
DAKT
Daktronics
COIN
ICCEUR
NASDAQ
BPYUP
Brookfield Property REIT
COIN
1K2USD
USOTC
BBBMD
Huntsman Exploration (PK)
EU
P916S
P916S
ASX
BXBISU
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados